During the past decade, Hospital Verge de la Cinta conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Verge de la Cinta" #1 sponsor was "PETHEMA Foundation" with 9 trials, followed by "Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau" with 3 trials sponsored, "Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias" with 3 trials sponsored, "Spanish Lung Cancer Group" with 2 trials sponsored and "ViiV Healthcare" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Verge de la Cinta" #1 collaborator was "Anagram-ESIC" with 1 trials as a collaborator, "Apices Soluciones S.L." with 1 trials as a collaborator, "Barcelona Supercomputing Center" with 1 trials as a collaborator, "BioClever 2005 S.L." with 1 trials as a collaborator and "Carlos III Health Institute" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Verge de la Cinta" are "Acute Lymphoblastic Leukemia" (3 trials), "Ischemic Stroke" (2 trials), "Leukemia, Myelocytic, Acute" (2 trials), "Lung Cancer" (2 trials) and "Acute Myeloblastic Leukemia" (1 trials). Many other conditions were trialed in "Hospital Verge de la Cinta" in a lesser frequency.

Most popular intervention types in "Hospital Verge de la Cinta" are "Drug" (19 trials), "Other" (7 trials), "Procedure" (4 trials), "Diagnostic Test" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ara-C" (3 trials), "Cyclophosphamide" (2 trials), "Cytarabine" (2 trials), "Daunorubicin" (2 trials) and "G-CSF" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Verge de la Cinta" are 30 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Verge de la Cinta". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Hospital Verge de la Cinta, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Verge de la Cinta, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 4 trials that are defined as “Not Applicable".